About
Calmare® Pain Therapy Treatment (Calmare) is a U.S FDA-cleared pain therapy medical device. Calmare is a non-invasive pain treatment which avoids the harmful, potentially fatal, adverse side effects and addictive properties linked to narcotic pain killers.
Calmare has successfully treated over 3,000 patients in the U.S. and Europe, where it has been shown to be effective in treating neuropathic and oncologic pain. Conditions treated include:
- All types of cancer
- Phantom Limb Syndrome
- Sciatica
- Post-surgical neuropathic pain
- Back pain
- Shingles
The device is currently being used in the US at these key teaching hospitals:
- University of Miami Pain Management Center
- Virginia Commonwealth University's Massey Cancer Center
- Paul Carbone Cancer Center at University of Wisconsin-Madison
Calmare was developed by Professor Giuseppe Marineo, a researcher and bioengineer and the founder and manager of Delta Research & Development. Delta R&D is the Bioengineering Research Centre affiliated with Tor Vergata University of Rome, Italy.
The device, with a biophysical rather than a biochemical approach, uses a multi-processor able to simultaneously treat multiple pain areas by applying surface electrodes to the skin. The device creates and sends a no-pain signal which becomes the dominant signal received by the brain, thus overriding the pain signal and providing relief for the patient.
The technology was brought to Competitive Technologies, Inc. (OTCQB: CTTIC) through the efforts of Prof. Giancarlo Elia Valori of the Italian business development group, Sviluppo Lazio S.p.A., and assistance from the Zangani Investor Community™. CTTC licensee 
GEOMC of Korea is manufacturing the device commercially for worldwide sales.
In honor of the technology's Italian inventor, CTTC chose to call this medical device "Calmare Pain Therapy Treatment." Translated from the Italian, "calmare" means "to soothe or ease." Calmare Pain Therapy Treatment eases the suffering that patients endure from debilitating pain.